Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03810365 · ClinicalTrials.gov registry record · NA
Brief Behavioral Treatment for Insomnia in Cancer Survivors
A NA study of Chronic Insomnia, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
- 2
- Study locations
NCT03810365: Completed NA study of Chronic Insomnia, sponsored by State University of New York at Buffalo.
NCT03810365 is a NA study of Chronic Insomnia that has completed, run by State University of New York at Buffalo. The registered enrollment target is 132 participants, below the 25,387-participant average among 11 other Chronic Insomnia trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03810365, a NA study of Chronic Insomnia, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose is to determine whether brief behavioral treatment is effective for insomnia in cancer survivors.
Primary Outcome
One month after the intervention, experimental group mean for Insomnia Severity Index will be compared to control group mean Insomnia Severity Index. The Insomnia Severity Index is a self report brief screening tool with seven items that asks respondents to rate the nature and symptoms of their sleep problems and the degree to which insomnia interferes with daily functioning and overall distress created by sleep problems using a likert type scale Scores between 0-7 have no clinically significan
Conditions Studied
Interventions
- BEHAVIORAL Brief behavioral treatment for insomnia
- BEHAVIORAL Healthy Eating Control
Study Locations (2)
New York
- University at Buffalo - Buffalo
- Roswell Park Comprehensive Cancer Center - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2019-06-06 |
| Est. Completion | 2023-11-01 |
| Phase | NA |
What the finished NCT03810365 record still lists
NCT03810365 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 25,387-participant average among 11 other Chronic Insomnia trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Chronic Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Brief behavioral treatment for insomnia is the first listed.
NCT03810365 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03810365 about?
NCT03810365 is a clinical study titled "Brief Behavioral Treatment for Insomnia in Cancer Survivors". The purpose is to determine whether brief behavioral treatment is effective for insomnia in cancer survivors.
What is the current status of trial NCT03810365?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2019-06-06. Estimated completion is 2023-11-01.
What conditions does trial NCT03810365 study?
This clinical trial studies the following conditions: Chronic Insomnia.
What interventions are being tested in trial NCT03810365?
The interventions under investigation include: Brief behavioral treatment for insomnia (BEHAVIORAL), Healthy Eating Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT03810365?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03810365 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03810365's enrollment target sits among peer trials
132 7th of 11 higher than 5 of 11 other Chronic Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Sleep and Reducing Opioid Use in Individuals With Chronic Pain
RECRUITING · NA
-
Insomnia Behavioral Intervention Study
RECRUITING · NA
-
Comparing Insomnia Care As Usual to Digital Augmentation (CICADA)
RECRUITING · NA
-
The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients
ACTIVE NOT RECRUITING · NA
-
Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study
COMPLETED · NA
-
Naturalistic Monitoring and Treatment of Chronic Insomnia
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI